Eurocell plc Director/PDMR Shareholding (6893G)
November 27 2020 - 1:00AM
UK Regulatory
TIDMECEL
RNS Number : 6893G
Eurocell plc
27 November 2020
27 November 2020
Eurocell plc
Director/PDMR Shareholding
Eurocell plc (the "Company") announces that, on 25 November
2020:
-- options granted on 4 April 2017 under the Eurocell plc
Deferred Share Plan 2015, to acquire ordinary shares in the
Company, were exercised by 2 directors; and
-- shares acquired, as a result of the above exercise, were sold
by 2 directors to cover the associated tax and national insurance
liabilities
The notifications set out below, made in accordance with the
requirements of the EU Market Abuse Regulation, provides further
details.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1. Details of PDMR / person closely associated with them ("PCA")
a) Name A - Mark Kelly
B - Michael Scott
------------------------------ -------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------------
a) Position / status A - Chief Executive Officer
B - Chief Financial Officer
------------------------------ -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
------------------------------ -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------
a) Name Eurocell plc
------------------------------ -------------------------------------------------
b) Legal Entity 213800RH62IQ7S9OFQ55
Identifier
------------------------------ -------------------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---------------------------------------------------------------------------------
a) Description Ordinary shares of GBP0.001 each in the Company
of the financial ("Ordinary Shares")
instrument ISIN Number GB00BVV2KN49
------------------------------ -------------------------------------------------
b) Nature of the Exercise of nil-cost options to acquire ordinary
transaction shares under the Eurocell plc Deferred Share
Plan 2015
------------------------------ -------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) A - GBPnil (option A - 51,049
price) B - 14,273
B - GBPnil (option
price)
------------
------------------------------ -------------------------------------------------
d) Aggregated information
* Aggregated volume
N/A - single transactions
* Aggregated price
* Aggregated total
------------------------------ -------------------------------------------------
e) Date of the 25 November 2020
transaction
------------------------------ -------------------------------------------------
f) Place of the Outside a trading venue
transaction
------------------------------ -------------------------------------------------
1. Details of PDMR / person closely associated with them ("PCA")
a) Name A - Mark Kelly
B - Michael Scott
------------------------------ -------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------------------
a) Position / status A - Chief Executive Officer
B - Chief Financial Officer
------------------------------ -------------------------------------------------------
b) Initial notification Initial Notification
/ amendment
------------------------------ -------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------------
a) Name Eurocell plc
------------------------------ -------------------------------------------------------
b) Legal Entity 213800RH62IQ7S9OFQ55
Identifier
------------------------------ -------------------------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---------------------------------------------------------------------------------------
a) Description Ordinary shares of GBP0.001 each in the Company
of the financial ("Ordinary Shares")
instrument ISIN Number GB00BVV2KN49
------------------------------ -------------------------------------------------------
b) Nature of the Sale of ordinary shares, acquired under the
transaction Eurocell plc Deferred Share Plan 2015, to cover
the associated tax and national insurance liabilities
------------------------------ -------------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) A - GBP2.125 A - 24,115
B - GBP2.125 B - 6,743
-----------
------------------------------ -------------------------------------------------------
d) Aggregated information
* Aggregated volume
N/A - single transactions
* Aggregated price
* Aggregated total
------------------------------ -------------------------------------------------------
e) Date of the 25 November 2020
transaction
------------------------------ -------------------------------------------------------
f) Place of the London Stock Exchange, Main Market (XLON)
transaction
------------------------------ -------------------------------------------------------
For further information:
Eurocell plc 01773 842 100
Paul Walker
Group Company Secretary
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHPPGQWGUPUGMQ
(END) Dow Jones Newswires
November 27, 2020 02:00 ET (07:00 GMT)
Eurocell (LSE:ECEL)
Historical Stock Chart
From Apr 2024 to May 2024
Eurocell (LSE:ECEL)
Historical Stock Chart
From May 2023 to May 2024
